Access to anti-retroviral drugs, female in Bulgaria

Bulgaria: Access to anti-retroviral drugs, female was 58.0% in 2024. ▲ Rising

Latest (2024)
58.0%
Change on year
up 7.4%
World rank
105th
of 141 countries
All-time high
58.0%
in 2024
All-time low
7.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Bulgaria, 2000–2024

02040602000201220242000: 7 %2001: 8 %2002: 9 %2003: 12 %2004: 14 %2005: 17 %2006: 18 %2007: 18 %2008: 20 %2009: 26 %2010: 29 %2011: 32 %2012: 35 %2013: 37 %2014: 37 %2015: 39 %2016: 40 %2017: 43 %2018: 45 %2019: 47 %2020: 49 %2021: 50 %2022: 56 %2023: 54 %2024: 58 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in Bulgaria is 58.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 7.4% on the previous year and up 56.8% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Bulgaria peaked at 58.0% in 2024 and was at its lowest, 7.0%, in 2000.

Bulgaria ranks 105th of 141 countries on this measure, in the middle of the range.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, female in Bulgaria, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Bulgaria, 2000 to 2024.
Year % Change
2000 7.0%
2001 8.0% +14.3%
2002 9.0% +12.5%
2003 12.0% +33.3%
2004 14.0% +16.7%
2005 17.0% +21.4%
2006 18.0% +5.9%
2007 18.0% +0.0%
2008 20.0% +11.1%
2009 26.0% +30.0%
2010 29.0% +11.5%
2011 32.0% +10.3%
2012 35.0% +9.4%
2013 37.0% +5.7%
2014 37.0% +0.0%
2015 39.0% +5.4%
2016 40.0% +2.6%
2017 43.0% +7.5%
2018 45.0% +4.7%
2019 47.0% +4.4%
2020 49.0% +4.3%
2021 50.0% +2.0%
2022 56.0% +12.0%
2023 54.0% -3.6%
2024 58.0% +7.4%

Averages by decade

DecadeAverage LowestHighest Years
2000s 14.9% 7.0% 26.0% 10
2010s 38.4% 29.0% 47.0% 10
2020s 53.4% 49.0% 58.0% 5

Countries ranked near Bulgaria

  1. 103 Kazakhstan 60.0% compare
  2. 103 Kyrgyzstan 60.0% compare
  3. 105 Kuwait 58.0% compare
  4. 105 Mexico 58.0% compare
  5. 108 Greece 57.0% compare
  6. 108 Timor-Leste 57.0% compare

See the full ranking of 160 places →

More gender data for Bulgaria

All data for Bulgaria →

Frequently asked questions

What is access to anti-retroviral drugs, female in Bulgaria?
Access to anti-retroviral drugs, female in Bulgaria was 58.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Bulgaria?
The highest recorded value was 58.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Bulgaria?
The lowest recorded value was 7.0% in 2000.
How does Bulgaria rank for access to anti-retroviral drugs, female?
Bulgaria ranks 105th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Bulgaria?
Over the last ten years it is up 56.8%. The long-run trend across the full record is rising.
Where does this Bulgaria data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Bulgaria. Statizoid, drawing on UNAIDS estimates. Retrieved 09 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/bulgaria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/bulgaria/">Access to anti-retroviral drugs, female in Bulgaria</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.